Difference between revisions of "GATA3"
Jump to navigation
Jump to search
| Line 6: | Line 6: | ||
Negative: | Negative: | ||
*[[Prostate carcinoma]]. | *[[Prostate carcinoma]]. | ||
*[[Squamous cell carcinoma of the lung]].<ref name=pmid22982890>{{Cite journal | last1 = Chang | first1 = A. | last2 = Amin | first2 = A. | last3 = Gabrielson | first3 = E. | last4 = Illei | first4 = P. | last5 = Roden | first5 = RB. | last6 = Sharma | first6 = R. | last7 = Epstein | first7 = JI. | title = Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung. | journal = Am J Surg Pathol | volume = 36 | issue = 10 | pages = 1472-6 | month = Oct | year = 2012 | doi = 10.1097/PAS.0b013e318260cde7 | PMID = 22982890 }}</ref> | |||
===Images=== | ===Images=== | ||
Revision as of 18:19, 18 September 2014
GATA3 an immunostain that is increasingly used in genitourinary pathology.
Positive:
Negative:
Images
See also
References
- ↑ 1.0 1.1 1.2 Chang A, Amin A, Gabrielson E, et al. (October 2012). "Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung". Am. J. Surg. Pathol. 36 (10): 1472–6. doi:10.1097/PAS.0b013e318260cde7. PMC 3444740. PMID 22982890. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3444740/. Cite error: Invalid
<ref>tag; name "pmid22982890" defined multiple times with different content Cite error: Invalid<ref>tag; name "pmid22982890" defined multiple times with different content